Singal A K, Rosman A S, Post J B, Bauman W A, Spungen A M, Korsten M A
Department of Medicine, James J. Peters VA Medical Center, Bronx, NY 10468, USA.
Aliment Pharmacol Ther. 2008 Jan 1;27(1):41-7. doi: 10.1111/j.1365-2036.2007.03558.x. Epub 2007 Oct 23.
Rare cases of nephrotoxicity have been reported with oral sodium phosphate solution (OSPS).
To evaluate whether OSPS is associated with changes in renal function.
A chart review performed on 311 patients who had colonoscopy at the James J. Peters VA Medical Centre prepared with either OSPS (n = 157) or polyethylene glycol (PEG) (n = 154). Patients had a baseline serum creatinine <or=1.5 mg/dL. Effect of bowel preparation on the renal function was evaluated by measuring the absolute change in levels of serum creatinine and the proportion of patients who developed a 50% or more increase above their baseline serum creatinine value.
Oral sodium phosphate solution resulted in a slight increase in serum creatinine from 1.0 +/- 0.02 to 1.1 +/- 0.02 mg/dL (P = 0.07) and PEG resulted in a small decrease in serum creatinine from 1.1 +/- 0.02 to 1.0 +/- 0.03 mg/dL (P = 0.03). The absolute change in serum creatinine was slightly higher with OSPS than with PEG (0.04 +/- 0.02 vs. -0.05 +/- 0.02 mg/dL; P = 0.005). However, the proportion of patients who had a >or=50% increase above their baseline creatinine was similar (OSPS vs. PEG, 5% vs. 3%, P = 0.77).
Oral sodium phosphate solution was associated with a slight increase in serum creatinine, which was not clinically significant. Renal toxicity from OSPS appears to be minimal when used in patients with serum creatinine value <1.5 mg/dL.
已有口服磷酸钠溶液(OSPS)导致肾毒性的罕见病例报道。
评估OSPS是否与肾功能变化相关。
对在詹姆斯·J·彼得斯退伍军人事务医疗中心接受结肠镜检查的311例患者进行病历回顾,这些患者分别使用OSPS(n = 157)或聚乙二醇(PEG)(n = 154)进行肠道准备。患者基线血清肌酐≤1.5mg/dL。通过测量血清肌酐水平的绝对变化以及血清肌酐值较基线升高50%或更多的患者比例,评估肠道准备对肾功能的影响。
口服磷酸钠溶液使血清肌酐从1.0±0.02mg/dL轻微升高至1.1±0.02mg/dL(P = 0.07),而PEG使血清肌酐从1.1±0.02mg/dL小幅下降至1.0±0.03mg/dL(P = 0.03)。OSPS导致的血清肌酐绝对变化略高于PEG(0.04±0.02 vs. -0.05±0.02mg/dL;P = 0.005)。然而,血清肌酐较基线升高≥50%的患者比例相似(OSPS组 vs. PEG组,5% vs. 3%,P = 0.77)。
口服磷酸钠溶液与血清肌酐轻微升高相关,但无临床意义。对于血清肌酐值<1.5mg/dL的患者,使用OSPS时肾毒性似乎极小。